Among the partner genes of RUNX2 identified by bioinformatic analysis, we chose to investigate the expression of the SSBP1 gene, involved in p53 transcriptional activity, and of the STMN1 gene, considered a melanoma oncogene, in order to evaluate the effects of RUNT deletion on malignant transformation. This evidence concerns the gene TP53 and melanoma.